Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$5.49 USD
-0.06 (-1.08%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $5.50 +0.01 (0.18%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/3/24 |
---|---|
Current Quarter | -0.65 |
EPS Last Quarter | -0.23 |
Last EPS Surprise | 55.77% |
ABR | 2.11 |
Earnings ESP
|
-34.88% |
---|---|
Current Year | -2.61 |
Next Year | -2.70 |
EPS (TTM) | -2.05 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.65M | 6.96M | 40.07M | 26.18M |
# of Estimates | 6 | 6 | 8 | 7 |
High Estimate | 27.50M | 14.70M | 65.00M | 31.50M |
Low Estimate | 5.00M | 2.50M | 25.02M | 20.00M |
Year ago Sales | 9.85M | 2.89M | 78.12M | 40.07M |
Year over Year Growth Est. | 18.30% | 140.66% | -48.72% | -34.66% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.65 | -0.63 | -2.61 | -2.70 |
# of Estimates | 8 | 6 | 12 | 10 |
Most Recent Consensus | -0.85 | -0.52 | -2.08 | -3.05 |
High Estimate | -0.44 | -0.46 | -1.84 | -1.72 |
Low Estimate | -0.89 | -0.75 | -3.76 | -3.67 |
Year ago EPS | -0.71 | -0.56 | -2.02 | -2.61 |
Year over Year Growth Est. | 8.45% | -12.50% | -29.21% | -3.25% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 3 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 0 |
Down Last 60 Days | 1 | 2 | 7 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.65 | -0.63 | -2.61 | -2.70 |
7 Days Ago | -0.65 | -0.63 | -2.61 | -2.70 |
30 Days Ago | -0.63 | -0.63 | -2.61 | -2.73 |
60 Days Ago | -0.63 | -0.62 | -2.48 | -2.75 |
90 Days Ago | -0.63 | -0.62 | -2.53 | -2.75 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.87 | -0.63 | -3.45 | -2.76 |
Zacks Consensus Estimate | -0.65 | -0.63 | -2.61 | -2.70 |
Earnings ESP | -34.88% | 0.00% | -31.97% | -2.14% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.23 | -0.55 | -0.56 | -0.71 | NA |
Estimate | -0.52 | -0.64 | -0.76 | -0.79 | NA |
Difference | 0.29 | 0.09 | 0.20 | 0.08 | 0.17 |
Surprise | 55.77% | 14.06% | 26.32% | 10.13% | 26.57% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more